کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2081906 | 1080236 | 2007 | 12 صفحه PDF | دانلود رایگان |

Heart failure secondary to myocardial infarction (MI) remains a major source of morbidity and mortality. Long-term outcome after MI can be largely be defined in terms of its impact on the size and shape of the left ventricle (i.e. LV remodeling). Three major mechanisms contribute to LV remodeling: (1) early infarct expansion, (2) subsequent infarct extension into adjacent noninfarcted myocardium and (3) late hypertrophy in the remote LV. Future developments in preventing post-MI heart failure will depend not only on identifying drugs targeting each of these individual mechanisms, but also on diagnostic techniques capable of assessing efficacy against each mechanism.
Section editor:Joel Linden – Department of Medicine, University of Virginia, Charlottesville, VA, USA
Journal: Drug Discovery Today: Disease Mechanisms - Volume 4, Issue 3, Autumn 2007, Pages 185–196